Brief: Novabay Says Laboratory Results Confirm Avenova Kills Sars-Cov-2 (Covid-19 Virus)
July 13 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS ANNOUNCES LABORATORY RESULTS
CONFIRM
AVENOVA KILLS SARS-COV-2 (COVID-19 VIRUS)
* NOVABAY PHARMACEUTICALS INC - TEST RESULTS WILL BE
SUBMITTED TO
EPA FOR EPA'S APPROVED LIST OF DISINFECTANTS FOR USE AGAINST
SARS-COV-2
* NOVABAY PHARMACEUTICALS INC - RESULTS AT 60 SECONDS PROVE
AVENOVA'S ABILITY TO FULLY INACTIVATE VIRUS
Source text for Eikon: ID:nBw9Lt4FRa
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing